Mohamed Fares

8PUBLICATIONS
37CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsChemotherapyTransition metal chemistryBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 10, 2026
Targeting CDK-2 With Novel Indole-Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies.

|Jun 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

|Oct 20, 2025
Structural insights into the activity of carbapenemases: understanding the mechanism of action of current inhibitors and informing the design of new carbapenem adjuvants.

Tahlia Hatzisarantinos, Elissar Mansour, Jonathan J Du

|Apr 16, 2025
Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors.

Mohamed A Zeidan, Mahmoud Abdelrahman Alkabbani, Simone Giovannuzzi

|Nov 17, 2024
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells.

Wagdy M Eldehna, Mohamed Fares, Alessandro Bonardi

|Jul 26, 2024
Platinum-based metal complexes as chloride transporters that trigger apoptosis.

Patrick Wang, Mohamed Fares, Radwa A Eladwy

Pageof 2

Frequent Collaborators

4 joint publications

Claudiu T Supuran

4 joint publications

Wagdy M Eldehna

3 joint publications

Haytham O Tawfik

2 joint publications

Alessio Nocentini